nicardipine has been researched along with Depression, Endogenous in 1 studies
Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.
Excerpt | Relevance | Reference |
---|---|---|
"The lipid-soluble calcium channel-blocking drug nicardipine or matching placebo were randomly assigned to 26 patients with major depressive disorder receiving ECT." | 5.09 | Nicardipine improves the antidepressant action of ECT but does not improve cognition. ( Buzan, R; Cullum, CM; Dubovsky, SL; Kassner, C; Thomas, M, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dubovsky, SL | 1 |
Buzan, R | 1 |
Thomas, M | 1 |
Kassner, C | 1 |
Cullum, CM | 1 |
1 trial available for nicardipine and Depression, Endogenous
Article | Year |
---|---|
Nicardipine improves the antidepressant action of ECT but does not improve cognition.
Topics: Adult; Age Factors; Calcium Channel Blockers; Cognition Disorders; Depressive Disorder; Double-Blind | 2001 |